AHF doubles down, pounding Gilead’s greed in SF Chronicle Ad

SAN FRANCISCO–(BUSINESS WIRE)–On Sunday, October 30, the AIDS Healthcare Foundation (AHF) will run a full-page, full-color advocacy ad targeting the pricing and policies of Bay Area drugmaker Gilead Sciences, Inc. The ad running in the San Francisco Chronicle is headed simply “greed,” but the word “greed” is scratched out with three red letters superimposed over the Gilead logo to form the word.

AHF’s ad is a long and growing list of Gilead’s greedy moves over the years on its HIV/AIDS and hepatitis C drugs that have added tens of billions of dollars to the company’s bottom line, largely at the expense of patients and community providers maintain and serve them. Points mentioned in the ad:

“Gilead is notorious for charging $1,000 for a single pill of the Hep-C drug Sovaldi

Gilead is being sued by thousands of HIV patients for knowingly selling a substandard drug until its patent expired out.

Gilead has replaced the inferior drug with Biktarvy and has now cut its patient assistance program.

Gilead’s price for HIV prevention drug Descovy has doubled in the past two years.

Gilead’s greed knows no bounds, making it the poster child for drug company profiteers.”

The Sunday Chronicle advertisement follows a successful baseline campaign which ends today (10/28). The campaign and protests, reported in the media by KPIX, KGO and the 340B report, spanned a week-long series of twice-daily protests by attorneys at Gilead’s headquarters in Foster City, California, during which groups raised drug prices and – sharply criticized the company’s guidelines.

Fifty-five AHF-affiliated advocates and mobilizers began protesting outside Gilead’s headquarters (333 Lakeside Dr., Foster City, CA 94404) at 8:30 am each day. Proponents regrouped and resumed each day at 12:00 p.m. PT. A larger theatrical protest with costumes (a $1 million bill, pigs’ heads and snouts, lawyers dressed as burglars with purses over their shoulders) took place on Wednesday.

The 340B drug pricing program is administered by the US Health Resources & Services Administration (HRSA). It has helped provide affordable medicines and better health outcomes to millions of Americans and the nonprofit clinics and hospitals that serve them. Safety net providers like Ryan White who care for HIV-infected patients have the right under the 340B statute to purchase drugs for their patients at a discounted rate. In March, Gilead put profits ahead of patients by unilaterally imposing unlawful conditions on when and how rebates will be given for certain hepatitis C drugs.

AIDS Health Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the United States, Africa, Latin America/Caribbean, Asia/Pacific and Eastern Europe. To learn more about CHD, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare


Leave a Reply

Your email address will not be published. Required fields are marked *